Effectiveness and safety of ferric carboxymaltose treatment to treat iron-deficiency anaemia in paediatric and adolescent patients with inflammatory bowel disease and/or other gastrointestinal diseases.
Phase of Trial: Phase III
Latest Information Update: 28 Oct 2015
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 28 Oct 2015 New trial record